Abstract
It is recognized that paracetamol undergoes a metabolic transformation to N-arachydonylphenolamine (AM404), a CB1 receptor ligand and anandamide uptake inhibitor. Using hot-plate and paw pressure tests, we decided to establish whether AM404 may act through opioidergic and serotonergic mechanisms. Thus, we pretreated rats with opioid μ1 (naloxonazine) and κ (MR2266) or 5-HT1A (NAN-190), 5-HT2 (ketanserin), and 5-HT3 (ondansetron) receptor antagonists. We investigated the possible changes in 5-hydroxyindoleacetic acid/serotonin ratio in the frontal cortex and pons. The antinociceptive effect of AM404 (10 mg/kg, intrapertoneally) or paracetamol (400 mg/kg, intrapertoneally) in either test was abolished by naloxonazine or MR2266. Ondansetron prevented AM404 activity; NAN-190 and ketanserin were ineffective. Ketanserin antagonized paracetamol activity; NAN-190 and ondansetron were inactive. AM404 did not change serotonergic activity, while paracetamol decreased serotonin turnover. The diverse antinociceptive potency of the compounds might be explained by the different influence on the serotonergic system, despite a similar involvement of opioidergic one.
Similar content being viewed by others
References
Abbott FV, Hellemans KG (2000) Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects. Behav Brain Res 112:177–186
Bardin L, Juordan D, Alloui A, Lavarenne J, Eschalier A (1997) Differential influence of two antagonists on spinal serotonin-induced analgesia in rats. Brain Res 765:267–272
Beltramo N, Piomelli D (2000) Carrier-mediated transport and enzymatic hydrolysis of endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11:1231–1253
Bjørklund A, Dunnett SB, Stenevi U, Lewis ME, Iversen SD (1980) Reinnervation of the denerved striatum by substantia nigra transplants: function consequences as revealed by pharmacological and sensomotor testing. Brain Res 199:307–333
Björkman R (1995) Central antinociceptive of non-steroidal anti-inflammatory drugs and paracetamol. Acta Anaesthesiol Scand 39(Suppl 103):7–43
Bonnefont J, Courade JP, Alloui A, Eschalier A (2003) Mechanism of the antinociceptive effect of paracetamol. Drugs 63:1–4
Boothman LJ, Mitchell SN, Sharp T (2006) Investigation of SSRI augmentation properties of 5-HT2 receptor antagonists in vivo microdialysis. Neuropharmacology 50:726–732
Braida D, Limonta V, Malabarba L, Zani A, Sala M (2007) 5-HT1A receptors are involved in the anxiolytic effect of Delta-9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor in Sprague–Dawley rats. Eur J Pharmacol 555:156–163
Chen C, Bazan NG (2003) Acetaminophen modifies hippocampal synaptic plasticity via a presynaptic 5-HT2 receptor. Neuroreport 14(5):743–747
Cichewicz DL (2004) Synergistic interactions between cannabinoid and opioid analgesics. Life Sci 74:1317–1324
Clissold SP (1986) Paracetamol and phenacetin. Drugs 32(Suppl 4):46–59
Courade JP, Chassaing C, Bardin L, Alloui A, Eschalier A (2001) 5-HT receptor subtypes involved in the spinal antinociceptive effect of acetaminophen in rats. Eur J Pharmacol 432:1–7
Duman EN, Kesim M, Kadioglu M, Yaris E, Kalyoncu I, Erciyes N (2004) Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J Pharmacol Sci 94:161–165
Fields H (2004) State-dependent opioid control of pain. Nat Rev Neurosci 5(7):565–575
Flegley D, Kathuria S, Mercier R, Li C, Goutopoulus A, Makriannis A, Piomelli D (2004) Anandamide transport is independent of fatty-acid hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci USA 101:8756–8761
Giuffrida A, Rodriguez de Fonseca F, Nava F, Loubet-Lescoulie P, Piomelli D (2000) Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur J Pharmacol 408:161–168
Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline but not 5-HT in the frontal cortex of freely-moving rats. Neuropharmacology 38:315–317
Gorzalka BB, Hill MN, Sun JC (2005) Functional role of endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes. Eur J Pharmacol 516:28–33
Grossi G, Bargossi A, Sprovieri G, Benagozzi V, Pasquale R (1990) Full automation of serotonin determination by column switching and HPLC. Chromatographia 30:61–68
Herrero JF, Headly PM (1996) Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID. Br J Pharmacol 118:968–972
Högestätt ED, Jönsson BA, Ermund A, Andersson DA, Björk H, Alexander JP, Cravatt BF, Basbaum AI, Zygmunt PM (2005) Conversion of acetaminophen to bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 280(36):31405–31412
Hunskaar S, Berge O-G, Hole K (1986) A modified hot-plate test sensitive to mild analgesics. Behav Brain Res 21:101–108
Johnson N, Pasternak GW (1984) Binding of 3H-naloxonazine to rat brain membranes. Mol Pharmacol 26:477–483
Le Bars D, Gorariu M, Cadden SW (2001) Animal models in nociception. Pharmacol Rev 53:597–652
Libert F, Bonnefont J, Bourinet E, Doucet E, Alloui A, Hammon M, Norgeot J, Eschalier A (2004) Acetaminophen: a central analgesic drug that involves a spinal tropisetron-sensitive, non 5-HT3 receptor mediated effect. Mol Pharmacol 66:728–734
Lipp J (1991) Possible mechanisms of morphine analgesia. Clin Neuropharmacol 14(2):131–147
Marek GJ (2003) Behavioral evidence of mu-opioid and 5-HT2A receptor interactions. Eur J Pharmacol 474:77–83
Millan MJ (2002) Descending control of pain. Progr Neurobiol 66:355–474
Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D, Giordano C, Di Marzo V, Mangoni GS, Rossi F, Maione S (2006) Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Eur J Neurosci 24:2011–2020
Pelissier T, Halloui A, Paeile C, Eschalier A (1995) Evidence in central antinociceptive effect of paracetamol involving spinal 5-HT3 receptors. Neuroreport 6:983–993
Pini LA, Sandrini M, Vitale G (1996) The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol 308:31–40
Pini LA, Vitale G, Ottani A, Sandrini M (1997) Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther 280:934–940
Randall LO, Selitto JJ (1957) A method for measurement of analgesic activity in inflamed tissue. Arch Int Pharmacodyn 61:409–417
Sandrini M, Vitale G, Ottani A, Pini LA (1999) The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in the rat brain. Inflamm Res 48:120–127
Sandrini M, Romualdi P, Capobianco A, Vitale G, Morelli G, Pini LA, Candeletti S (2001) The effect of paracetamol on nociception and dynorphin A levels in the rat brain. Neuropeptides 35:110–116
Sandrini M, Pini LA, Vitale G (2003) Different involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol. Inflamm Res 52:347–352
Sandrini M, Vitale G, Ruggieri V, Pini LA (2007) Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. Inflamm Res 56:139–142
Scherrer G, Befort K, Contett C, Becker J, Matifas A, Kiefer BL (2004) The delta agonists DPDE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta, and combinatorial opioid receptor knock out mice. Eur J Neurosci 19:2239–2248
Schoffelmeer ANM, Hogenboom F, Wardeh G, De Vries TJ (2006) Interaction between CB1 and µ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Neuropharmacology 51:773–781
Snedecor GW, Cochran WJ (1980) Statistical methods. Iowa State University Press, Ames, IA, p 298
Sufka KJ, Shomburg FM, Giordano J (1992) Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 41:53–56
Torres-Escalante JL, Barral JA, Ibarra-Villa MD, Pérez-Burgos A, Gongóra-Alfaro JL, Pineda JC (2004) 5-HT1A, 5-HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2/3 somatosensory rat cortex as evaluated by the paired pulse control. J Neurosci Res 78(2):268–278
Watkins LR, Mayer DJ (1986) Multiple endogenous opiate and non-opiate analgesia systems: evidence of their existence and clinical implications. Ann NY Acad Sci 467:273–299
Werner MU, Nielsen PR, Romsing J, Garcia Rodriguez LA, Hernandez-Diaz S (2002) Acetaminophen and upper gastrointestinal complications. Epidemiology 13:605–606
Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M (2006) Morphine can produce analgesia via spinal kappa opioid receptors in absence of mu opioid receptors. Brain Res 1083:61–69
Zhang YQ, Gao X, Zhang LM, Wu GC (2000) The release of serotonin in rat spinal dorsal horn and periaqueuctal gray following carrageenan inflammation. Neuroreport 11:3539–3543
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruggieri, V., Vitale, G., Pini, L.A. et al. Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol. Naunyn-Schmied Arch Pharmacol 377, 219–229 (2008). https://doi.org/10.1007/s00210-008-0284-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-008-0284-9